Carregant...
EGFR/HER-targeted therapeutics in ovarian cancer
Despite decades of research and evolving treatment modalities, survival among patients with epithelial ovarian cancer has improved only incrementally. During this same period, the development of biologically targeted therapeutics has improved survival for patients with diverse malignancies. Many of...
Guardat en:
| Publicat a: | Future Med Chem |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4620931/ https://ncbi.nlm.nih.gov/pubmed/22416774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4155/fmc.12.11 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|